Literature DB >> 34920053

CD99 in malignant hematopoiesis.

Atham Ali1, Vijaya Pooja Vaikari1, Houda Alachkar2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34920053      PMCID: PMC9450008          DOI: 10.1016/j.exphem.2021.12.363

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.249


× No keyword cloud information.
  56 in total

1.  CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion.

Authors:  J H Hahn; M K Kim; E Y Choi; S H Kim; H W Sohn; D I Ham; D H Chung; T J Kim; W J Lee; C K Park; H J Ree; S H Park
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

2.  MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.

Authors:  Noemí Aguilera-Montilla; Elvira Bailón; Rebeca Uceda-Castro; Estefanía Ugarte-Berzal; Andrea Santos; Alejandra Gutiérrez-González; Cristina Pérez-Sánchez; Philippe E Van den Steen; Ghislain Opdenakker; José A García-Marco; Angeles García-Pardo
Journal:  Oncogene       Date:  2019-02-13       Impact factor: 9.867

3.  CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.

Authors:  M N Dworzak; G Fröschl; D Printz; L De Zen; G Gaipa; R Ratei; G Basso; A Biondi; W-D Ludwig; H Gadner
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

4.  Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia.

Authors:  Vijaya Pooja Vaikari; Mincheol Park; Lena Keossayan; J Andrew MacKay; Houda Alachkar
Journal:  Nanomedicine       Date:  2020-06-12       Impact factor: 5.307

5.  Significance of CD99 expression in T-lineage acute lymphoblastic leukemia.

Authors:  Azza A Aboul Enein; Hala A Abdel Rahman; Nahla El Sharkawy; Samah Abd Elhamid; Sonia M A Abbas; Rafaat Abdelfaatah; Mohamed Khalil; Lamiaa A Fathalla
Journal:  Cancer Biomark       Date:  2016-03-18       Impact factor: 4.388

6.  CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.

Authors:  Marika Sciandra; Maria Teresa Marino; Maria Cristina Manara; Clara Guerzoni; Maria Grano; Angela Oranger; Enrico Lucarelli; Pier-Luigi Lollini; Barbara Dozza; Loredana Pratelli; Maria Flavia Di Renzo; Mario Paolo Colombo; Piero Picci; Katia Scotlandi
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

7.  Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.

Authors:  Charlotte V Cox; Paraskevi Diamanti; John P Moppett; Allison Blair
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 8.  Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.

Authors:  Irene Della Starza; Sabina Chiaretti; Maria S De Propris; Loredana Elia; Marzia Cavalli; Lucia A De Novi; Roberta Soscia; Monica Messina; Antonella Vitale; Anna Guarini; Robin Foà
Journal:  Front Oncol       Date:  2019-08-07       Impact factor: 6.244

9.  CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion.

Authors:  Lais C Cardoso; Roseli da S Soares; Talita de S Laurentino; Antonio M Lerario; Suely K N Marie; Sueli Mieko Oba-Shinjo
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

Review 10.  'Acute myeloid leukemia: a comprehensive review and 2016 update'.

Authors:  I De Kouchkovsky; M Abdul-Hay
Journal:  Blood Cancer J       Date:  2016-07-01       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.